Tacrolimus and mycophenolate mofetil vs tacrolimus and sirolimus in SPK, pancreas after kidney or pancreas transplant alone

Trial Profile

Tacrolimus and mycophenolate mofetil vs tacrolimus and sirolimus in SPK, pancreas after kidney or pancreas transplant alone

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Tacrolimus (Primary) ; Mycophenolate mofetil; Sirolimus
  • Indications Kidney-pancreas transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 03 Jun 2015 Planned End Date changed from 1 May 2015 to 1 May 2017 as reported by ClinicalTrials.gov record.
    • 03 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 May 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top